ENSEMBLE
E854996
ENSEMBLE is the large, global Phase 3 clinical trial that evaluated the safety and efficacy of Johnson & Johnson’s single-dose Ad26.COV2.S COVID-19 vaccine.
All labels observed (1)
| Label | Occurrences |
|---|---|
| ENSEMBLE canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T10292400 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
Target entity: ENSEMBLE Context triple: [Ad26.COV2.S, trialName, ENSEMBLE]
-
A.
Ensemble alliance
Ensemble alliance is a centrist political coalition in France formed around President Emmanuel Macron to support his reformist agenda and parliamentary majority.
-
B.
Nieuw Ensemble
Nieuw Ensemble is a contemporary music ensemble from the Netherlands known for its innovative programming and collaborations with modern composers.
-
C.
agung ensemble
The agung ensemble is a traditional Manobo gong ensemble featuring large, suspended bossed gongs used in ritual, ceremonial, and communal music-making in the southern Philippines.
-
D.
Hewar ensemble
Hewar ensemble is a contemporary Syrian music group known for blending Arabic classical traditions with jazz and improvisational elements.
-
E.
Unison
Unison is the English-language debut studio album by Canadian singer Celine Dion, released in 1990 and featuring pop ballads that helped launch her international career.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Target entity: ENSEMBLE Target entity description: ENSEMBLE is the large, global Phase 3 clinical trial that evaluated the safety and efficacy of Johnson & Johnson’s single-dose Ad26.COV2.S COVID-19 vaccine.
-
A.
Ensemble alliance
Ensemble alliance is a centrist political coalition in France formed around President Emmanuel Macron to support his reformist agenda and parliamentary majority.
-
B.
Nieuw Ensemble
Nieuw Ensemble is a contemporary music ensemble from the Netherlands known for its innovative programming and collaborations with modern composers.
-
C.
agung ensemble
The agung ensemble is a traditional Manobo gong ensemble featuring large, suspended bossed gongs used in ritual, ceremonial, and communal music-making in the southern Philippines.
-
D.
Hewar ensemble
Hewar ensemble is a contemporary Syrian music group known for blending Arabic classical traditions with jazz and improvisational elements.
-
E.
Unison
Unison is the English-language debut studio album by Canadian singer Celine Dion, released in 1990 and featuring pop ballads that helped launch her international career.
- F. None of above. chosen
Statements (40)
| Predicate | Object |
|---|---|
| instanceOf |
COVID-19 vaccine trial
ⓘ
Phase 3 clinical trial ⓘ clinical trial ⓘ |
| controlType | placebo ⓘ |
| diseaseTarget | COVID-19 NERFINISHED ⓘ |
| doseRegimen | single dose ⓘ |
| efficacyAssessment | monitored incidence of laboratory-confirmed COVID-19 ⓘ |
| endpoint |
assessment of safety profile
ⓘ
prevention of moderate to severe COVID-19 ⓘ prevention of severe COVID-19 ⓘ |
| evaluatedProduct |
Ad26.COV2.S
NERFINISHED
ⓘ
Johnson & Johnson single-dose COVID-19 vaccine ⓘ |
| geographicScope | multiple countries ⓘ |
| interventionType | vaccine ⓘ |
| pathogenTarget | SARS-CoV-2 NERFINISHED ⓘ |
| population | adult participants ⓘ |
| primaryObjective | evaluate efficacy of Ad26.COV2.S against COVID-19 ⓘ |
| regimenCharacteristic | single-shot COVID-19 vaccine ⓘ |
| relatedVaccineName |
Ad26.COV2.S COVID-19 vaccine
GENERATED
ⓘ
Janssen COVID-19 Vaccine GENERATED ⓘ |
| safetyAssessment | monitored adverse events after vaccination ⓘ |
| scope |
global
ⓘ
large ⓘ |
| secondaryObjective |
evaluate immunogenicity of Ad26.COV2.S
ⓘ
evaluate safety of Ad26.COV2.S ⓘ |
| sponsor |
Janssen Pharmaceutical Companies of Johnson & Johnson
NERFINISHED
ⓘ
Johnson & Johnson NERFINISHED ⓘ |
| sponsorCountry | United States NERFINISHED ⓘ |
| sponsorOrganizationType | pharmaceutical company ⓘ |
| sponsorType | industry ⓘ |
| studyDesign |
double-blind
ⓘ
placebo-controlled ⓘ randomized ⓘ |
| therapeuticArea |
infectious diseases
ⓘ
vaccinology ⓘ |
| trialCategory | pivotal efficacy trial ⓘ |
| trialContext | COVID-19 pandemic NERFINISHED ⓘ |
| trialPhase | Phase 3 ⓘ |
| vaccinePlatform | adenoviral vector vaccine ⓘ |
| vaccineVector | recombinant, replication-incompetent human adenovirus serotype 26 (Ad26) ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Subject: ENSEMBLE Description of subject: ENSEMBLE is the large, global Phase 3 clinical trial that evaluated the safety and efficacy of Johnson & Johnson’s single-dose Ad26.COV2.S COVID-19 vaccine.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.